Screening of nonpolyenic antifungal metabolites produced by clinical isolates of actinomycetes.

Can J Microbiol

UMR CNRS Ecologie Microbienne (Center for Microbial Ecology), Labratoire de Mycologie Fondamentale et Appliquée aux Biotechnologies Industrielles, Institut des Sciences Pharmaceutiques et Biologiques de Lyon, Université Claude Bernard Lyon, France.

Published: November 2003

The purpose of this work was to screen clinical isolates of actinomycetes producing nonpolyenic antifungals. This choice was made to limit the problem of rediscovery of well-known antifungal families, especially polyenic antifungals. One hundred and ten strains were tested, using two diffusion methods and two test media, against three yeast species and three filamentous fungi. Among 54 strains (49%) showing antifungal activity, five strains belonging to the genus Streptomyces were active against all test organisms and appeared promising. These results indicate that clinical and environmental isolates of actinomycetes could be an interesting source of antifungal bioactive substances. The production of nonpolyenic antifungal substances by these five active isolates was investigated using several criteria: antibacterial activity, ergosterol inhibition, and UV-visible spectra of active extracts. One active strain responded to all three selection criteria and produced potentially nonpolyenic antifungal metabolites. This strain was retained for further investigation, in particular, purification, structure elucidation, and mechanism of action of the active product.

Download full-text PDF

Source
http://dx.doi.org/10.1139/w03-088DOI Listing

Publication Analysis

Top Keywords

nonpolyenic antifungal
12
isolates actinomycetes
12
antifungal metabolites
8
clinical isolates
8
antifungal
6
active
5
screening nonpolyenic
4
metabolites produced
4
produced clinical
4
isolates
4

Similar Publications

Fungal diseases are currently a serious public health problem, due to the limited number of fact-based effective principles, and the emergence of resistant strains to the polyenic antifungals. The aim of this study was to screen, for non-polyenic antifungals production by Actinobacteria, and to validate the screening program by characterizingthe produced compounds.Actinobacteria isolates were tested against four clinic human-pathogenic fungi isolated from Hospital Mohammed V Rabat, Morocco.

View Article and Find Full Text PDF

A non-polyenic antifungal produced by a Streptomyces yatensis strain isolated from Mellah Lake in El Kala, North-East of Algeria.

J Mycol Med

March 2015

Laboratory of genetic improvement of plants and adaptation, Team of water, soil, and microorganisms, Department of Biology, Badji Mokhtar University, PO box 12, 23000 Annaba, Algeria.

Objective: This study aimed at describing one actinomycete strain E65 that was isolated from the water of Mellah Lake in El Kala, North-East of Algeria that produces a non-polyenic antifungal.

Materials And Methods: Actinomycetes were isolated from Mellah Lake water and screened for antimicrobial activity. Antimicrobial assays were performed on ISP2 agar.

View Article and Find Full Text PDF

Antimicrobial compounds produced by Actinomadura sp. AC104 isolated from an Algerian Saharan soil.

Can J Microbiol

April 2006

Laboratoire de Recherche sur les Produits Bioactifs et la Valorisation de la Biomasse, Ecole Normale Supérieure de Kouba, Biskra.

During a search for nonpolyenic antifungal antibiotics, an actinomycete designated AC104 was isolated from a Saharan soil sample by a dilution agar plating method using a chitin - vitamins B medium supplemented with rifampicin. Isolate AC104 presented the morphological and the chemical characteristics of the genus Actinomadura. On the basis of 76 physiological tests and 16S rDNA analysis, this isolate was determined to be quite different from the known species of Actinomadura.

View Article and Find Full Text PDF

Screening of nonpolyenic antifungal metabolites produced by clinical isolates of actinomycetes.

Can J Microbiol

November 2003

UMR CNRS Ecologie Microbienne (Center for Microbial Ecology), Labratoire de Mycologie Fondamentale et Appliquée aux Biotechnologies Industrielles, Institut des Sciences Pharmaceutiques et Biologiques de Lyon, Université Claude Bernard Lyon, France.

The purpose of this work was to screen clinical isolates of actinomycetes producing nonpolyenic antifungals. This choice was made to limit the problem of rediscovery of well-known antifungal families, especially polyenic antifungals. One hundred and ten strains were tested, using two diffusion methods and two test media, against three yeast species and three filamentous fungi.

View Article and Find Full Text PDF

An antibiotic (AH7) produced by Streptosporangium roseum strain 214 was investigated. This compound was extracted with chloroform from the filtrate culture and purified using thin-layer chromatography and high pressure liquid chromatography procedures. The antibiotic strongly inhibited the growth of several strains of fungi and bacteria known to be plant and human pathogens.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!